Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome

Summary

Phase II, randomized controlled, unblinded clinical trial. Will evaluate whether the administration of oral cyclosporine started on day 0 of transplantation is effective in reducing the incidence of cytokine release syndrome (CRS) in patients who receive an outpatient haploidentical transplant.

Timeline

Start

2021-03-25

Primary completion

2023-01-17

Completion

2023-02-17

Drugs

Indications